Related Experiment Video
Updated: May 19, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
[Meta-analysis of probiotics preventing allergic diseases in infants]
Lu-jing Tang1, Jie Chen, Yi Shen
1Department of Gastroenterology, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Insights
Probiotic supplementation during pregnancy and after birth effectively prevents pediatric atopic eczema. This intervention shows no significant preventive effect on other allergic conditions like asthma or food allergies.
Area of Science:
- Immunology
- Microbiology
- Pediatrics
Context:
- Pediatric allergic diseases represent a significant global health concern.
- The role of gut microbiota in immune system development and allergy prevention is increasingly recognized.
- Probiotics, live microorganisms conferring a health benefit, are being investigated for their potential in modulating immune responses.
Purpose:
- To evaluate the efficacy of probiotic supplementation in preventing pediatric allergic diseases.
- To synthesize evidence from randomized controlled trials (RCTs) on probiotic use for allergy prevention in children.
- To determine if probiotics can reduce the incidence of atopic eczema, sensitization, food allergy, and asthma.
Summary:
- A meta-analysis of 15 RCTs involving 3604 children was conducted.
- Prenatal and postnatal probiotic supplementation significantly reduced the risk of pediatric atopic eczema (RR 0.78).
- Supplementation exclusively after birth further decreased atopic eczema risk (RR 0.75), while Lactobacillus alone showed a stronger effect (RR 0.57).
Impact:
- Probiotic supplementation demonstrates a clear preventive effect against pediatric atopic eczema.
- The findings suggest a targeted approach for probiotic use in allergy prevention strategies.
- Further research may explore specific probiotic strains and optimal timing for maximal efficacy.
Objective:
To assess the preventive effect of probiotics against pediatric allergic diseases.
Method:
The authors searched all randomized controlled trials on the preventive effect of probiotics on pediatric allergic diseases from 8 databases (Pubmed, Medline, Springer link, highwire, Cochrane, Vip, Wanfang Data and CNKI) up to September 2011. Two reviewers assessed the studies to see if they meet inclusion criteria, and extracted data. Meta-analysis for the result of homogenous studies was made with RevMan 4.2 and the co-effect was pooled by using fixed-effects model of relative risk (RR) ratios.
Result:
Fifteen studies published between April 2001 and September 2011 including 3604 cases were included. All included studies were graded on randomization, allocation concealment, blinding, baseline and loss to follow-up. Meta-analysis based on included studies showed that prenatal and postnatal probiotic supplementation had preventive effect on pediatric atopic eczema by reducing the RR to 0.78 (95%CI: 0.70 - 0.88, P < 0.0001), and 3 studies in which probiotic was given only after birth, the RR was further reduced to 0.75 (95%CI: 0.66 - 0.86, P < 0.0001). Meta analysis for the effect of lactobacilus alone and combined with other bacteria showed that both decreased the RR ratios of 0.57 (95%CI: 0.44 - 0.73, P < 0.0001) and 0.79 (95%CI: 0.64 - 0.97, P = 0.02), respectively.
Conclusion:
Present evidences show that prenatal and postnatal probiotic supplementation will prevent pediatric atopic eczema, but not other allergic diseases such as sensitization, food allergy and asthma.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Related Concept Videos
Probiotics
Development of Human Microbiota
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Development of the Oral Microbiota